Skip to main navigation Skip to search Skip to main content

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: A European early-onset dementia consortium study

  • on behalf of the BELNEU Consortium and of the EU EOD Consortium
  • Department of Molecular Genetics
  • VIB Center for Inflammation Research
  • Antwerp University
  • Hospital Network Antwerp Middelheim and Hoge Beuken
  • Leuven University Center for Metabolic Bone Diseases
  • Karolinska Institutet
  • Karolinska Institutet at Karolinska University Hospital
  • Center for Applied Medical Research
  • Hospital Mútua de Terrassa
  • National Institute of Health Carlos III
  • Clínica Universitaria de Navarra
  • Technical University of Munich
  • IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli
  • University of Florence
  • Hospital Clínic, CIBERNED, IDIBAPS
  • University of Coimbra, Center for Neuroscience and Cell Biology
  • Universitat Autònoma de Barcelona
  • Faculdade de Medicina, Universidade de Lisboa
  • University of Brescia
  • Charles University
  • Thomayer Hospital
  • Institut Català de Neurociències Aplicades
  • Geneva University Hospitals
  • University of Verona
  • University Medical Center Groningen

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Meta-analysis of existing genome-wide association studies on Alzheimer's disease (AD) showed subgenome-wide association of an intronic variant in the sequestosome 1 (SQSTM1) gene with AD. We performed targeted resequencing of SQSTM1 in Flanders-Belgian AD patients selected to be enriched for a genetic background (n = 435) and geographically matched nonaffected individuals (n = 872) to investigate the role of both common and rare SQSTM1 variants. Results were extended to the European early-onset dementia cohorts (926 early-onset Alzheimer's disease [EOAD] patients and 1476 nonaffected individuals). Of the 61 detected exonic variants in SQSTM1, the majority were rare (n = 57). Rare variant (minor allele frequency <0.01) burden analysis did not reveal an increased frequency of rare variants in EOAD patients in any of the separate study populations nor when meta-analyzing all cohorts. Common variants p.D292= and p.R312= showed nominal association with AD (odds ratiop.D292== 1.11 [95% confidence interval= 1-1.22], p= 0.04), only when including the Flanders-Belgian cohort in the meta-analysis. We cannot exclude a role of SQSTM1 genetic variability in late-onset AD, but our data indicate that SQSTM1 does not play a major role in the etiology of EOAD.

Original languageEnglish
Pages (from-to)2005.e15-2005.e22
JournalNeurobiology of Aging
Volume36
Issue number5
DOIs
StatePublished - 2015
Externally publishedYes

Keywords

  • Alzheimer's disease
  • European early-onset dementia consortium
  • Meta-analysis
  • Rare variants
  • SQSTM1/p62

Fingerprint

Dive into the research topics of 'Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: A European early-onset dementia consortium study'. Together they form a unique fingerprint.

Cite this